- Home
- SYRE vs GLOB Comparison
SYRE vs GLOB Comparison
Compare SYRE & GLOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | GLOB |
|---|---|---|
| Founded | 2013 | 2003 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | 2015 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SYRE | GLOB |
|---|---|---|
| Price | $42.92 | $45.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 14 |
| Target Price | $60.13 | ★ $79.14 |
| AVG Volume (30 Days) | 659.5K | ★ 1.4M |
| Earning Date | 05-07-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $3.06 |
| Revenue Next Year | N/A | $5.30 |
| P/E Ratio | ★ N/A | $22.55 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.91 | $40.77 |
| 52 Week High | $45.76 | $142.25 |
Technical Indicators
Market Signals| Indicator | SYRE | GLOB |
|---|---|---|
| Relative Strength Index (RSI) | 59.57 | 38.25 |
| Support Level | $15.01 | $40.77 |
| Resistance Level | $45.76 | $71.47 |
| Average True Range (ATR) | 2.15 | 2.14 |
| MACD | -0.19 | 0.23 |
| Stochastic Oscillator | 67.85 | 24.43 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About GLOB Globant S.A.
Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.